Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Du F, Wang W, Li M (2020) Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer. Breast Cancer Res Treat https://doi.org/10.1007/s10549-020-05648-9

    Article  PubMed  Google Scholar 

  2. 2.

    Poggio F, Bruzzone M, Ceppi M (2018) Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Ann Oncol 29:1497–1508. https://doi.org/10.1093/annonc/mdy127

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Paluch-Shimon S, Cardoso F, Partridge AH (2020) ESO-ESMO 4th international consensus guidelines for Breast Cancer in Young Women (BCY4). Ann Oncol. https://doi.org/10.1016/j.annonc.2020.03.284

    Article  PubMed  Google Scholar 

  4. 4.

    Lambertini M, Campbell C, Bines J (2019) Adjuvant anti-HER2 therapy, treatment-related amenorrhea, and survival in premenopausal HER2-positive early breast cancer patients. JNCI J Natl Cancer Inst 111:86–94. https://doi.org/10.1093/jnci/djy094

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Lambertini M, Goldrat O, Toss A (2017) Fertility and pregnancy issues in BRCA-mutated breast cancer patients. Cancer Treat Rev 59:61–70. https://doi.org/10.1016/j.ctrv.2017.07.001

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Matteo Lambertini.

Ethics declarations

Conflicts of interest

Matteo Lambertini acted as a consultant for Roche and Novartis, and received speaker honoraria from Takeda, Theramex, Roche, Lilly, Novartis and Pfizer outside the submitted work. The other authors declare no conflicts of interest in relation to this article.

Ethical approval

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Perachino, M., Poggio, F. & Lambertini, M. Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer. Breast Cancer Res Treat (2020). https://doi.org/10.1007/s10549-020-05767-3

Download citation